Sino Biological,Inc. (SHE:301047)
China · Delayed Price · Currency is CNY 103.94
-7.46 (-6.70%)
Oct 22, 2026, 4:00 PM EDT
Sino Biological,Inc. Market Cap
Sino Biological,Inc. has a market cap or net worth of 12.64 billion as of October 22, 2026. It is the 6,786th most valuable company in the world and the 1,226th biggest in China. Its market cap has increased by 43.37% in one year.
Market Cap
12.64B
Enterprise Value
9.56B
Revenue
768.00M
Global Rank
Country Rank
#1,226 China
PE Ratio
76.51
ChartMarket Cap Chart
Since August 16, 2021, Sino Biological,Inc.'s market cap has decreased from 33.55B to 12.64B, a decrease of -62.31%. That is a compound annual growth rate of -17.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 12.64B | 53.76% |
| Dec 31, 2025 | 8.22B | 9.30% |
| Dec 31, 2024 | 7.52B | -29.33% |
| Dec 29, 2023 | 10.65B | -17.32% |
| Dec 30, 2022 | 12.88B | -45.23% |
| Dec 31, 2021 | 23.51B | -29.92% |
| Aug 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Acrobiosystems | 15.95B |
| Sinocelltech Group | 15.85B |
| HitGen | 14.88B |
| Jinyu Bio-technology | 13.99B |
| BrightGene Bio-Medical Technology | 13.95B |
| Anhui Anke Biotechnology (Group) | 13.40B |
| GemPharmatech | 11.95B |
| Nanjing Vazyme Biotech | 11.53B |